Literature DB >> 18474182

The treatment of hypertension in obese patients.

Marion R Wofford1, Grant Smith, Deborah S Minor.   

Abstract

Hypertension causes a significant disease burden in all racial and ethnic groups and is directly attributable to excess weight in most cases. The relationship between increasing body mass index and hypertension prevalence has been recognized for decades. Epidemiologic studies clearly demonstrate the correlation between body weight and blood pressure in obese and lean populations. Most patients with hypertension are overweight or obese, and loss of excess weight lowers blood pressure. Although the epidemiologic relationship is clear, the understanding of mechanisms linking hypertension and weight gain is still evolving. Lifestyle modifications and specific pharmacologic agents address many of the known mechanisms; however, blood pressure remains difficult to control in obese hypertensive patients. This review highlights the association of obesity and hypertension, identifies potential mechanisms for this association, and describes nonpharmacologic and pharmacologic strategies that offer potential benefits for the obese patient with hypertension.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18474182     DOI: 10.1007/s11906-008-0027-9

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  50 in total

Review 1.  Obesity-associated hypertension: new insights into mechanisms.

Authors:  Kamal Rahmouni; Marcelo L G Correia; William G Haynes; Allyn L Mark
Journal:  Hypertension       Date:  2004-12-06       Impact factor: 10.190

2.  Antihypertensive effect of alpha- and beta-adrenergic blockade in obese and lean hypertensive subjects.

Authors:  M R Wofford; D C Anderson; C A Brown; D W Jones; M E Miller; J E Hall
Journal:  Am J Hypertens       Date:  2001-07       Impact factor: 2.689

3.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

4.  Role of selective leptin resistance in diet-induced obesity hypertension.

Authors:  Kamal Rahmouni; Donald A Morgan; Gina M Morgan; Allyn L Mark; William G Haynes
Journal:  Diabetes       Date:  2005-07       Impact factor: 9.461

5.  Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study.

Authors:  André J Scheen; Nick Finer; Priscilla Hollander; Michael D Jensen; Luc F Van Gaal
Journal:  Lancet       Date:  2006-11-11       Impact factor: 79.321

Review 6.  Pathophysiology and treatment of obesity hypertension.

Authors:  Marion R Wofford; John E Hall
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

7.  Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation.

Authors:  F Massiéra; M Bloch-Faure; D Ceiler; K Murakami; A Fukamizu; J M Gasc; A Quignard-Boulange; R Negrel; G Ailhaud; J Seydoux; P Meneton; M Teboul
Journal:  FASEB J       Date:  2001-10-15       Impact factor: 5.191

8.  Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.

Authors:  Stevo Julius; Sverre E Kjeldsen; Michael Weber; Hans R Brunner; Steffan Ekman; Lennart Hansson; Tsushung Hua; John Laragh; Gordon T McInnes; Lada Mitchell; Francis Plat; Anthony Schork; Beverly Smith; Alberto Zanchetti
Journal:  Lancet       Date:  2004-06-19       Impact factor: 79.321

9.  Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea.

Authors:  David A Calhoun; Mari K Nishizaka; Mohammad A Zaman; Susan M Harding
Journal:  Chest       Date:  2004-01       Impact factor: 9.410

Review 10.  Obesity, sleep apnea, and hypertension.

Authors:  Robert Wolk; Abu S M Shamsuzzaman; Virend K Somers
Journal:  Hypertension       Date:  2003-11-10       Impact factor: 10.190

View more
  6 in total

Review 1.  Obesity-Associated Hypertension: the Upcoming Phenotype in African-American Women.

Authors:  Rohan Samson; Andrea Qi; Abhishek Jaiswal; Thierry H Le Jemtel; Suzanne Oparil
Journal:  Curr Hypertens Rep       Date:  2017-05       Impact factor: 5.369

2.  Does chocolate reduce blood pressure? A meta-analysis.

Authors:  Karin Ried; Thomas Sullivan; Peter Fakler; Oliver R Frank; Nigel P Stocks
Journal:  BMC Med       Date:  2010-06-28       Impact factor: 8.775

3.  Medical complications of obesity and optimization of the obese patient for colorectal surgery.

Authors:  Nell Maloney Patel; Manish S Patel
Journal:  Clin Colon Rectal Surg       Date:  2011-12

4.  Is resected stomach volume related to weight loss after laparoscopic sleeve gastrectomy?

Authors:  Jagat Pal Singh; Om Tantia; Tamonas Chaudhuri; Shashi Khanna; Prateek H Patil
Journal:  Obes Surg       Date:  2014-10       Impact factor: 4.129

Review 5.  The relationship between obesity and hypertension: an updated comprehensive overview on vicious twins.

Authors:  Massimo Leggio; Mario Lombardi; Elisa Caldarone; Paolo Severi; Stefania D'Emidio; Massimo Armeni; Veronica Bravi; Maria Grazia Bendini; Andrea Mazza
Journal:  Hypertens Res       Date:  2017-10-05       Impact factor: 3.872

6.  Utilization of antihypertensive drugs in obesity-related hypertension: a retrospective observational study in a cohort of patients from Southern Italy.

Authors:  Mauro Cataldi; Ornella di Geronimo; Rossella Trio; Antonella Scotti; Andrea Memoli; Domenico Capone; Bruna Guida
Journal:  BMC Pharmacol Toxicol       Date:  2016-03-16       Impact factor: 2.483

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.